Galvis Ingrid, Siepmann Timo, Tamayo Arturo, Harnegie Mary Pat, Fregni Felipe
Principles and Practice of Clinical Research (PPCR) Program, ECPE, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Radiology, Columbia University Irving Medical Center, New York, NY, USA.
Int J Gen Med. 2025 Aug 20;18:4601-4613. doi: 10.2147/IJGM.S526262. eCollection 2025.
Phantom limb pain (PLP) constitutes a diagnostic and therapeutic challenge with an unknown pathophysiology that likely comprises a combination of cerebral, spinal, and peripheral nervous system pathways. A novel therapeutic field in chronic pain targets cortical areas as treatment foci for neuropathic pain. One studied target in phantom limb pain is the primary motor cortex (M1). Given some promising results of noninvasive brain stimulation to reduce PLP, understanding further the role of M1 in the mechanisms of PLP would provide important future insights to further develop this therapeutic target.
To synthesize neuroimaging evidence on M1 reorganization in PLP and evaluate its association with pain intensity.
Six databases (Ovid MEDLINE, Cochrane Library, CINAHL, Scopus, Web of Science and EMBASE) were searched.
Of the 2582 articles, 13 articles met our criteria and were included. Evidence demonstrated cortical reorganization in the contralateral M1, characterized by increased activation and maintained functional representation of the absent limb, lasting decades post-amputation. Patients with PLP showed significant activation in M1 and the somatosensory cortex during phantom limb movements, alongside reduced interhemispheric functional connectivity. However, results regarding the relationship between M1 reorganization and PLP intensity were inconsistent.
M1 cortical reorganization plays a substantial role in PLP mechanisms, making it a viable therapeutic target. The inconsistent correlation between M1 activity and PLP severity highlights the complexity of PLP pathophysiology. Future research should standardize imaging protocols, control for confounding variables, and investigate interactions between M1 and other brain regions to improve therapeutic approaches.
幻肢痛(PLP)是一个诊断和治疗上的挑战,其病理生理学尚不清楚,可能涉及大脑、脊髓和周围神经系统通路的综合作用。慢性疼痛治疗的一个新领域将皮质区域作为神经性疼痛的治疗靶点。幻肢痛研究的一个靶点是初级运动皮层(M1)。鉴于非侵入性脑刺激在减轻幻肢痛方面取得了一些有前景的结果,进一步了解M1在幻肢痛机制中的作用将为进一步开发这一治疗靶点提供重要的未来见解。
综合关于幻肢痛中M1重组的神经影像学证据,并评估其与疼痛强度的关联。
检索了六个数据库(Ovid MEDLINE、Cochrane图书馆、CINAHL、Scopus、科学引文索引和EMBASE)。
在2582篇文章中,13篇符合我们的标准并被纳入。证据表明对侧M1存在皮质重组,其特征是激活增加且缺失肢体的功能代表得以保留,在截肢后持续数十年。幻肢痛患者在幻肢运动期间M1和体感皮层有显著激活,同时半球间功能连接减少。然而,关于M1重组与幻肢痛强度之间关系的结果并不一致。
M1皮质重组在幻肢痛机制中起重要作用,使其成为一个可行的治疗靶点。M1活动与幻肢痛严重程度之间不一致的相关性凸显了幻肢痛病理生理学的复杂性。未来的研究应规范成像方案,控制混杂变量,并研究M1与其他脑区之间的相互作用,以改进治疗方法。